Shopping Cart 0
Cart Subtotal
USD 0

Global and Chinese Inosine Pranobex Market Outlook 2017-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3100

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Inosine pranobex, also known as inosine acedoben dimepranol (IAD), is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. IAD is an immunomodulator which is indicated for the treatment of cell mediated immune deficiencies associated with various viral infections.

The report covers forecast and analysis for the inosine pranobex market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the inosine pranobex market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the inosine pranobex market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global inosine pranobex market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the inosine pranobex market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Applications

Pharmaceutical

Veterinary

Key Regions

North America

Europe

Asia Pacific

China

Key Vendors

Newport Pharmaceuticals

Zhejiang Shengxiao

Zhengzhou Sigma

Tuoxin

Mingxin Pharm

Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the global inosine pranobex market?

What are the challenges to market growth?

Who are the key players in the inosine pranobex market?

What are the market opportunities and threats faced by the key players?

READ MORE

Table Of Content

Scope

Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Geographic Scope

2.3 Years Considered

Part 3. Market Overview

3.1 Introduction

3.2 Global Inosine Pranobex Market, by Volume, by Company 2012-2017

3.2.1 Overview

3.2.2 Global Inosine Pranobex Market, by Volume, by Company

3.2.3 Top 3 Companies by Volume Share

3.3 Global Inosine Pranobex Market, by Revenue, by Company 2012-2017

3.3.1 Overview

3.3.2 Global Inosine Pranobex Market, by Revenue, by Company

3.3.3 Top 3 Companies by Revenue Share

Part 4. Market Dynamics

4.1 Market Drivers

4.2 Challenges

4.3 Market Trends

Part 5. Segmentation by Application

5.1 Overview

5.2 Pharmaceutical

5.3 Veterinary

Part 6. Segmentation by Region

6.1 Global Inosine Pranobex Volume by Region

6.1.1 North America

6.1.2 Europe

6.1.3 Asia-Pacific

6.1.4 China

6.2 Global Inosine Pranobex Revenue by Region

6.2.1 North America

6.2.2 Europe

6.2.3 Asia-Pacific

6.2.4 China

6.3 Global Inosine Pranobex Consumption by Region

6.3.1 North America

6.3.2 Europe

6.3.3 Asia-Pacific

6.3.4 China

Part 7. Inosine Pranobex Market Forecast

7.1 Global Inosine Pranobex Market Size 2017-2022

7.2 Global Inosine Pranobex Market by Region 2017-2022

7.2.1 North America

7.2.2 Europe

7.2.3 Asia-Pacific

7.2.4 China

7.3 Global Inosine Pranobex Market by Application 2017-2022

Part 8. Company Profiles

8.1 Newport Pharmaceuticals

8.1.1 Business Overview

8.1.2 Products Offered

8.1.3 Financials

8.2 Zhejiang Shengxiao

8.3 Zhengzhou Sigma

8.4 Tuoxin

8.5 Mingxin Pharm

...

Part 9. Appendix

9.1 Abbreviations

9.2 Disclaimer

Licence Rights

Single License

allows one individual to access the purchased report

Site License

allows five individuals to access the purchased report

Enterprise License

allows all employees of an organization to access the purchased report

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com